about
Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cellsInhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseasesUrsodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.Glycolytic ATP fuels the plasma membrane calcium pump critical for pancreatic cancer cell survival.Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy.MGMT Expression Predicts PARP-Mediated Resistance to Temozolomide.MiRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
P50
Q33838195-E777C59D-C52A-43E1-A718-1DF984FF00BBQ35185224-E8DB6E9B-64C6-4DFC-853F-5B870C95659DQ36075389-C3D46F8A-73D5-4D9B-97F8-158775B820ADQ37388840-D744A32C-B826-4F94-A72B-4D31D42FFC51Q38572735-AF461F5A-973C-44FF-B91F-A489ABDF737DQ38898999-537837CB-1E7B-4DBD-82C0-770AFCD7F5EBQ47784988-399E0A34-9C94-49F4-A95F-236C4B0FBA63Q48821774-95B6AC60-A1E5-4374-8DD0-AA4479F3A8CCQ50062968-FE34DDCD-41D1-4A3C-AF7C-3C5F476BD918
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Oihane Erice
@ast
Oihane Erice
@en
Oihane Erice
@es
Oihane Erice
@nl
type
label
Oihane Erice
@ast
Oihane Erice
@en
Oihane Erice
@es
Oihane Erice
@nl
prefLabel
Oihane Erice
@ast
Oihane Erice
@en
Oihane Erice
@es
Oihane Erice
@nl
P31
P496
0000-0002-9894-1356